Author:
Shelekhov A. V.,Dvornichenko V. V.,Radostev S. I.,Morikov D. D.,Rasulov R. I.,Ushakova I. V.,Medvednikov A. A.,Zaharov A. G.,Demonov R. N.,Gladkova O. V.,Chernorubashkina N. M.
Abstract
We present our experience in using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer patients treated at Irkutsk Regional Cancer Center. All patients were divided into 2 groups. Group I consisted of 15 patients, who underwent cytoreductive surgery only. Group II comprised 17 patients, who underwent surgery and HIPEC. The main eligibility criteria for this study were verified peritoneal carcinomatosis and resectable ovarian cancer. The primary analysis of these groups included: preoperative period, length of operation, postoperative length of stay, and postoperative complications. The technique of performing HIPEC using Performer HT® (RAND, Medolla (MO), Italy) was completely described. Further study is required to estimate the difference in overall and disease-free survival between study groups.
Publisher
Tomsk Cancer Research Institute
Reference8 articles.
1. Aebi S., Castiglione M.; ESMO Guidelines Working Group. Newly and relapsed epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009 May; 20 Suppl 4: 21–3. doi: 10.1093/annonc/mdp117.
2. Practical guidelines on the medicinal treatment of malignant tumors. Malignant tumors. 2017; 7 (3): 135–145. [in Russian]
3. Winter W.E.3rd, Maxwell G.L., Tian C., Carlson J.W., Ozols R.F., Rose P.G., Markman M., Armstrong D.K., Muggia F., McGuire W.P.; Gynecologic Oncology Group Study. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2007; 25: 3621–7.
4. Amanov S.B., Shanazarov N.A., Privalov A.V. The role of hyperthermic intraoperativ intraperitontal chemoperfusion in treatment of malignant neoplasms and abdominal carcinomatosis. Modern Problems of Science and Education. 2013; 6: 661. [in Russian]
5. Savinova A.R., Gataullin I.G. Personalized approach to the ovarian cancer treatment. Kazan Medical Journal. 2016; 97 (3): 388–393. doi: 10.17750/KMJ2016-388. [in Russian]
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献